WHO Public Assessment Reports (WHOPARs) published
M
Past News
Paediatric dispersible abacavir/lamivudine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Micro Labs’ dolutegravir/lamivudine/tenofovir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Withdrawal of Vector Control TC products and the corresponding reference profiles supporting WHO Specifications
VCP
Recently, seven active ingredient Technical Material (TC) products, previously evaluated by WHO, were withdrawn by the recognized applicants. In so doing, the applicants
ITN Product Review Report
VCP
WHO PQT/VCP recently published the following report - Product Review Report - Insecticide Treated Nets Formulated with Pyrethroid+PBO and Pyrethroid+2nd Ac
Gilead’s remdesivir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First nirmatrelvir + ritonavir prequalified for Covid-19
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
M
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
Revised Invitation for Expression of Interest (EOI) for medicines against HIV infection and related diseases published
M
The 20th Invitation for Expression of Interest (EOI) for medicines against HIV infection and related diseases, is published with the following changes:
A) The following products
Hetero’s ritonavir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Two PQT Medicines trainings for regulators in 2022
M
Two PQT Medicines (virtual) trainings for regulators will take palce during June 2022.
Zhejiang Apeloa’s levofloxacin tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Suspension of supply of COVID-19 vaccine (COVAXIN®)
V
The World Health Organization (WHO) is today confirming the suspension of supply of Covaxin produced by Bharat, through UN procurement agencies and recommending to countries that received the vacci
COVID-19 PANDEMIC AND EMERGENCY USE LISTING
IVD
Emergency Use Listing (EUL) for candidate in vitro diagnostics (IVDs) to detect SARS-CoV-2 remains ongoing.
Remdesivir added to COVID-19 Invitation for Expression of Interest (EOI)
M
Remdesivir invited for COVID-19:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
M
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
Addition under section:
First entecavir products prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
First levonorgestrel intrauterine delivery system (IUS) prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
PRESENTATIONS AVAILABLE - Joint UNICEF‒UNFPA‒WHO Meeting for Manufacturers and Suppliers
ID
IVD
IS
M
V
VCP
Presentations of the Joint UNICEF-UNFPA-WHO Meeting with Manufacturers and Suppliers which took place from 08 to 10 March 2022 are now available on the following page: